№ lp_1_2_36355
Public health advisory outlining epidemiology, clinical presentation, testing protocols, vaccination considerations, and treatment pathways for mpox in Massachusetts based on current surveillance and outbreak data.
Year: 2024
Region: Massachusetts, United States
Document type: Public health advisory
Issuing authority: Massachusetts Department of Public Health
Office: Executive Office of Health and Human Services
Bureau: Bureau of Infectious Disease and Laboratory Sciences
Subject: Mpox clinical guidance, laboratory testing, vaccination, and treatment
Target audience: Healthcare providers, hospitals, community health centers, emergency medical services, local boards of health
Date of issue: April 2, 2024
Disease focus: Mpox (monkeypox virus)
Virus clades referenced: MPXV Clade IIb, MPXV Clade I
Testing facilities: Massachusetts State Public Health Laboratory, commercial laboratories
Treatment referenced: Tecovirimat (TPOXX), STOMP clinical trial, CDC EA-IND protocol
Vaccination referenced: Jynneos vaccine
Epidemiological period covered: October 2023 to March 2024
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.